Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-12 6:32 pm Purchase | 2026-03-31 | 13G | REPLIMUNE GROUP INC REPL | SUVRETTA CAPITAL MANAGEMENT LLC | 4,221,836 5.100% | 4,221,836 (New Position) | Filing History |
| 2026-05-12 6:24 pm Sale | 2026-03-31 | 13G | ERASCA INC ERAS | SUVRETTA CAPITAL MANAGEMENT LLC | 3,434,967 1.100% | -11,067,037 (-76.31%) | Filing History |
| 2026-05-12 6:15 pm Purchase | 2026-03-31 | 13G | ZURA BIO LTD ZURA | SUVRETTA CAPITAL MANAGEMENT LLC | 9,524,263 9.900% | 3,957,262 (+71.08%) | Filing History |
| 2026-05-08 6:52 pm Purchase | 2026-05-01 | 13D | AVALON TECHNOLOGY GROUP INC CO AVLN | SUVRETTA CAPITAL MANAGEMENT LLC | 2,503,109 5.600% | 2,503,109 (New Position) | Filing History |
| 2026-05-05 9:39 pm Purchase | 2026-05-01 | 13D | VERADERMICS INC MANE | SUVRETTA CAPITAL MANAGEMENT LLC | 4,172,121 9.900% | 3,130 (+0.08%) | Filing History |
| 2026-04-13 5:03 pm Purchase | 2026-04-06 | 13G | LEXEO THERAPEUTICS INC LXEO | SUVRETTA CAPITAL MANAGEMENT LLC | 5,674,778 7.700% | 5,674,778 (New Position) | Filing History |
| 2026-02-26 7:10 pm Purchase | 2026-02-19 | 13G | CAPRICOR THERAPEUTICS INC CAPR | SUVRETTA CAPITAL MANAGEMENT LLC | 3,417,891 6.600% | 3,417,891 (New Position) | Filing History |
| 2026-02-13 4:50 pm Unchanged | 2025-12-31 | 13G | SUTRO BIOPHARMA INC STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2026-02-13 4:49 pm Sale | 2025-12-31 | 13G | SUTRO BIOPHARMA INC STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% | -648,832 (Position Closed) | Filing History |
| 2026-02-13 4:46 pm Purchase | 2025-12-31 | 13G | ZURA BIO LTD ZURA | SUVRETTA CAPITAL MANAGEMENT LLC | 5,567,001 8.600% | 706,062 (+14.53%) | Filing History |
| 2026-02-13 4:41 pm Sale | 2025-12-31 | 13G | IMMATICS N V IMTX | SUVRETTA CAPITAL MANAGEMENT LLC | 11,190,129 8.300% | -840,000 (-6.98%) | Filing History |
| 2026-02-13 4:32 pm Purchase | 2025-12-31 | 13G | INFLARX N V COM IFRX | SUVRETTA CAPITAL MANAGEMENT LLC | 7,933,910 11.700% | 2,200,000 (+38.37%) | Filing History |
| 2026-02-13 4:27 pm Purchase | 2025-12-31 | 13G | BIOHAVEN RESH LTD. USD COM SHS BHVN | SUVRETTA CAPITAL MANAGEMENT LLC | 10,286,937 7.800% | 5,714,101 (+124.96%) | Filing History |
| 2026-02-11 5:22 pm Purchase | 2026-02-05 | 13D | VERADERMICS INC MANE | SUVRETTA CAPITAL MANAGEMENT LLC | 4,168,991 11.900% | 4,168,991 (New Position) | Filing History |
| 2025-11-13 5:31 pm Purchase | 2025-09-30 | 13G | PALVELLA THERAPEUTICS INC PVLA | SUVRETTA CAPITAL MANAGEMENT LLC | 822,400 7.400% | 107,937 (+15.11%) | Filing History |
| 2025-11-13 5:24 pm Sale | 2025-09-30 | 13G | 89BIO INC ETNB | SUVRETTA CAPITAL MANAGEMENT LLC | 8,280,000 5.600% | -6,331,409 (-43.33%) | Filing History |
| 2025-11-10 9:53 pm Purchase | 2025-11-07 | 13D | BENITEC BIOPHARMA INC BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 17,761,945 44.100% | 2,138,286 (+13.69%) | Filing History |
| 2025-08-21 09:07 am Purchase | 2025-08-13 | 13G | COMPASS THERAPEUTICS INC CMPX | SUVRETTA CAPITAL MANAGEMENT LLC | 14,101,159 8.200% | 6,951,666 (+97.23%) | Filing History |
| 2025-08-13 9:02 pm Sale | 2025-06-30 | 13G | PEPGEN INC PEPG | SUVRETTA CAPITAL MANAGEMENT LLC | 300,000 0.900% | -1,360,932 (-81.94%) | Filing History |
| 2025-08-13 8:47 pm Purchase | 2025-06-30 | 13G | SUTRO BIOPHARMA INC STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 648,832 7.700% | 71,013 (+12.29%) | Filing History |